Nevada Expansion Latest in String of Big Moves by Plus Products


Tony Deyes

October 16th, 2019

App, Exclusive, News, Top News


As cannabis companies become more established, many choose to become multi-state operators, with assets and operations in a number of US legal markets.

Most companies have achieved this through acquisitions and strategic partnerships with companies having existing assets and licenses, allowing companies to gain control over cultivation and processing facilities, licensing, and often retail operations and distribution chains, rapidly increasing capacity and augmenting or achieving vertical integration, key benefits of multi-state operations.

As new markets emerge, multi-state operators can build on the lessons learned elsewhere and more easily transition into them.

Up until now, Plus Products (CSE: PLUS, OTCQB: PLPRF) has operated with a laser focus on California, the world’s single largest adult-use cannabis market = becoming one of the state’s premier edibles brand. PLUS is the state’s top-ranked gummies brand, boasting both the #1 and #2 best-selling cannabis products across all categories.

Click here to see the company investor presentation

Following closely on the heels of the nationwide launch of its 100% hemp-derived CBD line in partnership with Casper Sleep and American superstar-philanthropist John Legend, this week the company announced that its best-selling THC-infused gummies are now available in Nevada’s recreational adult use market.

Nevada a Natural Fit

Nevada is a key market for building an internationally-recognized brand and advancing the company’s transition into a multi-state operator.

Nevada legalized cannabis for adult recreational use on January 1, 2017 and, buoyed by a flourishing tourism industry, which attracts over 45 million visitors a year, retail sales quickly exceeded expectations, and are now predicted to surpass  $1.2 billion by 2022 according to a report by Arcview Market Research & BDS Analytics. Like California, Nevada’s edible products continue to grow in popularity, growing from 14.5% of recreational sales in Q3 2017 to 18% today according to BDS Analytics.

Taproot Partnership Advances Expansion

The plan for an expansion into Nevada was realized through a partnership with Taproot Holdings Inc, a vertically-integrated cannabis company, which has provided PLUS with space in its licensed facility to produce PLUS’s signature infused gummies.

Click here to see the company investor presentation

This model is ideal as it allowed PLUS to quickly and easily deploy its machinery, ingredients and people to ensure its products maintain the consistently high quality standards consumers have come to expect, with commercialization coming just four months after PLUS and Taproot entered into a definitive agreement.

Jake Heimark, co-founder and CEO of Plus said, “Operating in Nevada only four months after signing a definitive agreement with TapRoot is a testament to our commitment to execution in building a national footprint. We have created and commercialized the best-selling gummies brand in California. Now with this expansion, we aim to replicate this successful strategy in Nevada and ensure high-quality cannabis products reach more consumers in the U.S.”

Availability

Plus infused gummies are currently available at three Medmen locations in Las Vegas, and a state-wide roll-out to dispensaries is planned in the coming weeks.

Its best-selling edibles are also available in over 360 licensed retailers across the state of California, and its line of 100% hemp-derived CBD-infused gummies are available for purchase nationwide at plusproducts.com.

The CBD line includes three distinct products, labeled in accordance with the company’s simplified brand strategy.  Each BALANCE Blueberry gummy is infused with 50mg of CBD, while UPLIFT Grapefruit gummies are infused with 50mg of CBD augmented by vitamin B, and SLEEP Blackberry Tea gummies contain 25mg of CBD and melatonin.

 

In late September, PLUS unveiled three new flavours at the Hall of Flowers cannabis trade show in Santa Rosa, California; Balance Cucumber Lime gummies contain 3.5mg THC and 1.5mg CBD each, while Uplift Tangerine gummies are infused with 5mg THC and <0.1mg CBD; and Unwind Concord Grape gummies have 4.5mg THC and 0.5mg CBD per piece. Plus is currently working on a line of infused chocolates, expected in Q1 2020.

Click here to see the company investor presentation

Further Expansions Coming

As of last year’s mid-term elections, 33 states have legalized cannabis for medical purposes, while ten of them and the District of Columbia have legalized cannabis for recreational adult use. In December, the 2018 Farm Bill was also signed into law, legalizing hemp and the production of hemp-derived CBD, enabling operations in states where other cannabis operations are still illegal. Attitudes are quickly shifting in favour of national legalization, and if that ever comes to fruition, multi-state operators will be better positioned to capitalize.

PLUS intends to expand to 5 additional states by the end of 2020 with  Arizona, Illinois, Massachusetts, Michigan, and New York at the top of the list for expansion. The company expects to use a similar partnership model to ensure quality and consistency across markets. At the pace Plus is moving, you’ll definitely want to keep a close eye on them.

Watch this page and visit https://www.plusproducts.com/ for updates.

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://cannabisfn.com(the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Tony Deyes



Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading